Ligand to Hold Third Quarter Results Conference Call on November 8
Ligand to Present at Acumen BioFin Rodman & Renshaw Health Conference on November 5
Ligand Earns Milestone Payment as Wyeth Submits European Market Authorization for Bazedoxifene
Ligand Research Published in Journal of Medicinal Chemistry: LGD-2941 Shows Promise in Treating Muscle and Bone Loss
Ligand to Ring Opening Bell at NASDAQ Stock Market Ceremony
Ligand Announces Positive Preclinical Data on Selective Androgen Receptor Modulator LGD-3303
Ligand to Present at Thomas Weisel Partners and Bear Stearns Healthcare Conferences in September
Ligand Pharmaceuticals Announces Second Quarter Results
Ligand to Hold Second Quarter Results Conference Call on August 8
Ligand Launches Redesigned Corporate Web Site
Ligand Pharmaceuticals Announces First Quarter Results
Ligand to Hold First Quarter Results Conference Call on May 10
Ligand Names John P. Sharp Chief Financial Officer
Ligand Pharmaceuticals Completes Dividend Distribution
